Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Medical profession

Doctors who take drug company payments prescribe more branded drugs

Doctors who accept payments from pharmaceutical companies write more prescriptions for branded drugs than those who don’t, according to a US report. 

The analysis, which was carried out by investigative news outlet ProPublica[1], found that doctors who received any kind of payment over the course of a year from a drug or device company were twice as likely to prescribe branded drugs at an exceptionally high rate compared with others in their speciality. 

The number of branded drug prescriptions also increased with the value of payments received. For example, internal medicine doctors who received payments of at least US$5,000 prescribed branded drugs at a rate of 30.1%, almost 10% more than those who received less than US$100 (20.7%).

Doctors who received speaking fees also had higher rates of branded drug prescriptions than those who received other types of payment. 

“This feeds into the ongoing conversation about the propriety of these sorts of relationships [between doctors and pharmaceutical companies],” says Aaron Kesselheim, an associate professor of medicine at Harvard Medical School who consulted on the analysis. “Hopefully we’re getting past the point where people will say ‘There’s no evidence that these relationships change physicians’ prescribing practices’,” he adds. 

The report matched prescription data from the Medicare programme, which covers around a quarter of all prescriptions made in the United States, with information from Open Payments, a US government initiative that makes public all payments made from drug and device companies to individual doctors. 

The study included 150,323 physicians from the five largest medical specialities in the United States (family medicine, internal medicine, cardiovascular disease, psychiatry, ophthalmology) who issued at least 1,000 prescriptions to Medicare beneficiaries in 2014.

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2016.20200924

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • Drugs of Abuse

    Drugs of Abuse

    A concise, easy-to-read guide for healthcare professionals who encounter drug abuse.

    £38.00Buy now
  • Pharmaceutical Toxicology

    Pharmaceutical Toxicology

    Explains the methodology and requirements of pre-clinical safety assessments of new medicines. Includes registration requirements and pharmacovigilance.

    £40.00Buy now
  • Adverse Drug Reactions

    Adverse Drug Reactions

    A practical guide to the drug reactions that affect particular organ systems, and the management of these reactions.

    £38.00Buy now
  • English Delftware Drug Jars

    English Delftware Drug Jars

    This beautiful book illustrates the art and history of the collection of English delftware drug jars in the Museum of the Royal Pharmaceutical Society of Great Britain.

    £54.00Buy now
  • Paediatric Drug Handling

    Paediatric Drug Handling

    Written for new pharmaceutical scientists, this book provides a background in paediatric pharmacy and a comprehensive introduction to children's medication.

    £33.00Buy now

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Supplementary images

  • Patient consulting with doctor

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.